Algorae Pharmaceuticals Limited has released a press release.
Extension of Rights Issue
Filed with ASX ·
6ix hasn’t read this filing yet.
Algorae Pharmaceuticals Limited on 6ix
Story so far
Earlier from Algorae Pharmaceuticals
- Prospectus- Rights Issue
- LCT- Rights Issue
- LCT Receives New Zealand R&D Tax Credit
- LCT Advises Price Change for Rights Issue
- LCT Signs MOU with NZeno, Secures Pig Cells for NTCELL Trial
Later from Algorae Pharmaceuticals
- Results of Rights Issue
- LCT Signs Service Agreement with NZeno
- Half Yearly Report and Accounts
- LCT Completes Strategic A$1.285M Placement
- Preliminary Final Report and 2022 Financial Statements
Follow Algorae Pharmaceuticals into a list and get an email when it puts out news.
Follow Algorae Pharmaceuticals